登录
免费注册
首页
论文
论文详情
赞
收藏
引用
分享
科研之友
微信
新浪微博
Facebook
分享链接
A preliminary report of a Phase II study of folinic acid, 5-fluorouracil, irinotecan (FOLFIRI) plus sunitinib with toxicity, efficacy, pharmacokinetics, biomarker, imaging data in patients with colorectal cancer with liver metastases as 1st line treatment - a study of the CESAR central european society for anticancer drug research - EWIV
作者:Mross K
*
; Buechert M; Fasol U; Jaehde U; Kanefendt F; Strumberg D; Arends J; Hense J; Moritz B; Fischer R; Scheulen M E
来源:
International Journal of Clinical Pharmacology and Therapeutics
, 2011, 49(1): 96-98.
DOI:10.5414/CPP49096
Phase II study
FOLFIRI
sunitinib
oncology
cytotoxics
cytostatics
biomarker
pharmacokinetics
DCE-MRI
CEUS
出版日期
2011-1
全文
全文
访问全文
相似论文
引用论文
参考文献